1. Frid AH, et al. New Insulin Delivery Recommendations. Mayo Clinic Proceedings. 2016;91(9):1231–1255
BD Micro-Fine™ Insulin syringes
Full portfolio of insulin syringes to support your patient's insulin delivery needs
Overview
embecta offers a full portfolio of insulin syringes desgined to help accurately deliver insulin for those who use a vial and a syringe
6mm- Shortest syringe needle from embecta
| The BD Microfine™ 6mm x 31G needle is the shortest insulin syringe needle length offered by embecta. Shorter needles are effective, well tolerated, less painful and may lower the risk of an accidental intramuscular injection, when compared to longer needles. Intramuscular injections can lead to unexplained hypoglycemia and greater injection pain.1 |
| Full range of needle lengths and barrel capacities |
| Across the diverse range of patient needs and preferences, our portfolio of BD Micro-Fine™ insulin syringes offer you choice and flexibility with availability in 1 mL, 0.5 mL, and 0.3 mL capacities, with 6 mm, 8 mm and 12.7 mm needles. |
| Easy to read |
| Designed with large dose unit markings, with ½ unit scale marking available on the 0.3mL barrel. |
| Single Use |
| Recommend the use of a new insulin syringe every time your patients inject. Insulin syringe needles are recommended to be used only once and are no longer sterile after that. There is an association between needle reuse and injection pain or bleeding.1 |
1. Frid AH, et al. New Insulin Delivery Recommendations. Mayo Clinic Proceedings. 2016;91(9):1231–1255
embecta, formerly part of BD. BD is the manufacturer of the advertised products.